Panvel, BRPNVLACNOR9

BTG Pactual raises Panvel stock profit outlook by 11 percent

Published on 10/16/2026 at 01:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Net income is forecast at BRL 185 million for 2026, up from BRL 176 million. Panvel stock has a BRL 19.00 target and a 5.9 percent 2026 margin.

Growth estimates and key dates

  • BTG Pactual lifted Panvel's adjusted net income forecast to BRL 185 million on September 22, 2026.
  • The 2026 margin forecast is 5.9 percent, while GLP-1 revenue grew 91 percent in the first half of 2026.
  • Panvel's next results are scheduled for November 5, 2026.
Panvel, BRPNVLACNOR9, Illustration mit AI erstellt.

Panvel stock (ISIN BRPNVLACNOR9) is tied to a higher adjusted net income forecast of BRL 185 million for 2026, up from BRL 176 million. BTG Pactual published the revised estimate on September 22, 2026 and kept its 2027 price target at BRL 19.00.

Results support higher estimates

The report followed Panvel's second-quarter 2026 results, which exceeded BTG Pactual's estimates. Panvel's net revenue reached BRL 1.51 billion in that quarter, an increase of 14.9 percent from the year-earlier period, while attributable IFRS profit was BRL 30.37 million, up 21.05 percent, according to TraderNews.

The operating mix is becoming more important for the investment case. BTG Pactual estimated that Panvel's GLP-1 revenue increased 91 percent in the first half of 2026 and forecast growth above 60 percent for the full year. The bank also projected a 5.9 percent 2026 EBITDA margin, 0.50 percentage points higher than its earlier level.

Three dated steps in the story

On August 6, 2026, Panvel reported second-quarter revenue of BRL 1.51 billion and attributable IFRS profit of BRL 30.37 million, as TraderNews stated. On September 21, 2026, the board approved BRL 18 million in interest on equity, according to Finance News. On September 22, 2026, BTG Pactual raised its adjusted net income forecast from BRL 176 million to BRL 185 million for 2026.

What dates matter next?

Panvel's next results are scheduled for November 5, 2026, with a webcast on November 6, 2026, according to TraderNews. The approved interest on equity is scheduled for payment in three installments of BRL 18 million in total, beginning March 31, 2028, according to Finance News.

Margin delivery is the key test

The numbers point to a two-sided operating picture. GLP-1 demand is expanding quickly, but BTG Pactual said gross margin fell 0.30 percentage points in the first half of 2026 as lower-margin products gained weight. Cost dilution and efficiency gains therefore need to deliver the projected 5.9 percent EBITDA margin for 2026.

Panvel's next operating checkpoint

Panvel's 2026 results date and the 5.9 percent margin forecast give investors two concrete markers for testing the revised earnings outlook.

Panvel stock facts

  • Company: Panvel Farmacias
  • ISIN: BRPNVLACNOR9
  • Ticker: PNVL3
  • Primary exchange: B3
  • Sector / Industry: Consumer Staples / Drug Retail

Market context: Market report Bovespa.

More news and analyses on Panvel stock

Disclaimer...
en | BRPNVLACNOR9 | PANVEL | boerse | 70334308 | bgmi